The molecular mechanisms of BRD7 gene in regulating of Rb/E2F pathway

Progress in Biochemistry and Biophysics

Volumn 34, Issue 8, 2007, Pages 881-888

  Li, Shu Fang ^a,b   Zhou, Ming ^a   Liu, Hua Ying ^a   Xu, Xiao Jie ^a   Peng, Cong ^a   Peng, Shu Ping ^a   Wu, Ming Hua ^a   Li, Xiao Ling ^a   Li, Gui Yuan ^a  

^a Central South University   (China)

^b HUNAN PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Antisense nucleic acids technology; BRD7 gene; Cell cycle regulation; Cyclin D1; Rb E2F pathway

Indexed keywords

EID: 35348967973     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yu Y, XieY, Li G Y, et al. Chin J Cancer, 2000, 19 (7) : 709-712
2. Yu Y, Xie Y, Li G Y, et al. Prog Biochem Biophys, 2000, 27 (3): 319-323
3. Zhan F H, Jiang N, Cao L, et al. Chin J Med Genet, 1998, 15 (6) : 341-344
4. Yu Y, Zhu S G, Zhang B C, et al. Sci China (Ser C), 2002, 32 (2): 153-158
5. Staal A, Enserink J M, Stein J L, et al. Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription-factor interferon regulatory factor 2. J Cell Physiol, 2000, 185 (2): 269-279
6. Hyshkowska J, Rusch A, Wolf H, et al. Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain containing protein BRD7. Biochem J, 2003, 371 (Pt 2): 385-393
7. Kim S, Lee J, Park J, et al. BP75, bromodomain-containing M(r) 75 000 protein, binds dishevelled-1 and enhances Wnt signaling by inactivating glycogen synthase kinase-3 beta. Cancer Res, 2003, 63 (16): 4792-4795
8. Yu Y, Zhu S G, Zhang B C, et al. Chin J Cancer, 2001,20 (6): 4-10
9. Zhou J, Ma J, Li G Y, et al. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J Chell Physiology, 2004, 200 (1): 89-98
10. Peng C, Tan C, Li X L, et al. Prog Biochem Biophys, 2003, 30 (5): 721-725
11. HMüller, J Lukas, A Schneider, et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA, 1994, 91 (8): 2945-2949
12. Zetterberg A, Larsson O, Wiman K G. What is the restriction point?. Curr Opin Cell Biol, 1995, 7 (6): 835-842
13. Blagosklonny M V, Pardee A B. The restriction point of the cell cycle. Cell Cycle, 2002, 1 (2): 103-110
14. Ritety D J, Liu C Y, Lee W H, et al. Mutations of N-terminal regions renders the Retinoblastoma protein insufficient functions in development and tumor suppression. Mol Col Biol, 1997, 17 (12): 7342-7352
15. Zeng Y X. Oncology. 2nd. Beijing: People Health Press, 2001. 158-165
16. Tao W, Levine A J. P19(ARF) stabilizes p53 by blocking nucleocytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA, 1999, 96 (12): 6937-6941
17. Sherr C J. Cdk inhibitors:positive and negative regulators of G1-Phase progression. Genes Dev, 1999, 13: 1501-1502